In multiple tumor types, such as liver, pancreatic, breast, and bladder cancers, PTEN expression has decreased, and is highly involved in the regulation of tumor suppressors that downregulate the signaling of Akt (protein kinase B) by reducing the release of PI3K to the cell membrane [6]. This evidence concerns the gene PTEN and neoplasm.